Fonte: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Assuntos: PARASITOLOGIA, PLASMODIUM, TRANSGENES, MALÁRIA, MEDICAMENTO
ABNT
CALIT, Juliana et al. Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds. Antimicrobial Agents and Chemotherapy, v. 62, n. 11, p. e01053-18, 2018Tradução . . Disponível em: https://doi.org/10.1128/AEM.00235-18. Acesso em: 12 set. 2024.APA
Calit, J., Dobrescu, I., Gaitán, X. A., Borges, M. H., Ramos, M. S., Eastman, R. T., & Bargieri, D. Y. (2018). Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds. Antimicrobial Agents and Chemotherapy, 62( 11), e01053-18. doi:10.1128/AEM.00235-18NLM
Calit J, Dobrescu I, Gaitán XA, Borges MH, Ramos MS, Eastman RT, Bargieri DY. Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 11): e01053-18.[citado 2024 set. 12 ] Available from: https://doi.org/10.1128/AEM.00235-18Vancouver
Calit J, Dobrescu I, Gaitán XA, Borges MH, Ramos MS, Eastman RT, Bargieri DY. Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds [Internet]. Antimicrobial Agents and Chemotherapy. 2018 ; 62( 11): e01053-18.[citado 2024 set. 12 ] Available from: https://doi.org/10.1128/AEM.00235-18